Last update 08 May 2025

Institute Of Basic Research In Clinical Medicine,China Academy Of Chinese Medical Sciences

Education|Beijing Shi, China

Overview

Tags

Nervous System Diseases
Respiratory Diseases
Cardiovascular Diseases
Herbal medicine

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
no Data
No Data
Disease DomainCount
Infectious Diseases1
Nervous System Diseases1
Top 5 Drug TypeCount
Herbal medicine2

Related

3
Drugs associated with Institute Of Basic Research In Clinical Medicine,China Academy Of Chinese Medical Sciences
Qingfei Paidu Granules
Target-
Mechanism-
Active Org.
Institute Of Basic Research In Clinical Medicine,China Academy Of Chinese Medical Sciences
Originator Org.
Institute Of Basic Research In Clinical Medicine,China Academy Of Chinese Medical Sciences
Active Indication
COVID-19
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
China
First Approval Date02 Mar 2021
Naonuo Shuning Granules
Target-
Mechanism-
Active Org.
Institute Of Basic Research In Clinical Medicine,China Academy Of Chinese Medical Sciences
Originator Org.
Institute Of Basic Research In Clinical Medicine,China Academy Of Chinese Medical Sciences
Active Indication
Blood Stasis [+1]
Inactive Indication-
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
Jiuwei Zhengxiao Granules
Target-
Mechanism-
Active Org.
Institute Of Basic Research In Clinical Medicine,China Academy Of Chinese Medical Sciences
Originator Org.
Institute Of Basic Research In Clinical Medicine,China Academy Of Chinese Medical Sciences
Active Indication
Primary Malignant Liver Neoplasm
Inactive Indication-
Drug Highest PhaseIND Approval
First Approval Ctry. / Loc.-
First Approval Date-
23
Clinical Trials associated with Institute Of Basic Research In Clinical Medicine,China Academy Of Chinese Medical Sciences
ITMCTR2024000770
/ SuspendedNot ApplicableIIT
An evaluation study on the clinical efficacy of Tanyutongzhi antihypertensive decoction in the intervention of high normal blood pressure population
ITMCTR2024000769
/ SuspendedNot ApplicableIIT
An evaluation study on the clinical efficacy of Tanyutongzhi antihypertensive decoction in the intervention of high normal blood pressure population
ChiCTR2400081274
/ SuspendedNot ApplicableIIT
Efficacy of acupuncture for menopausal syndrome after hormone therapy in breast cancer: a case registry study
100 Clinical Results associated with Institute Of Basic Research In Clinical Medicine,China Academy Of Chinese Medical Sciences
Login to view more data
0 Patents (Medical) associated with Institute Of Basic Research In Clinical Medicine,China Academy Of Chinese Medical Sciences
Login to view more data
100 Deals associated with Institute Of Basic Research In Clinical Medicine,China Academy Of Chinese Medical Sciences
Login to view more data
100 Translational Medicine associated with Institute Of Basic Research In Clinical Medicine,China Academy Of Chinese Medical Sciences
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 14 Jun 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
IND Approval
1
1
Phase 2 Clinical
Approved
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Qingfei Paidu Granules
COVID-19
More
Approved
Naonuo Shuning Granules
Blood Stasis
More
Phase 2
Jiuwei Zhengxiao Granules
Primary Malignant Liver Neoplasm
More
IND Approval
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free